Elevated lymphocyte count at time of acute myeloid leukemia diagnosis is associated with shorter remission
Authors:
- 12 May 2015
- journal article
- Published by Taylor & Francis in Leukemia & Lymphoma
- Vol. 56 (11) , 3109-3115
Abstract
In solid tumors, decreased absolute lymphocyte count (ALC) at diagnosis was found to be associated with poorer outcome, but there is only limited data on the impact of ALC in acute myeloid leukemia (AML). In this study we evaluated the prognostic value of ALC on outcome in 259 adult patients with AML who responded to induction therapy. Higher than normal ALC at diagnosis was associated with shorter remission (HR 4.06; p < 0.001), and decreased relapse free and overall survival (HR 3.47; p < 0.001 and HR 3.85; p < 0.001 respectively). Flow cytometry showed low frequency of natural killer (NK) cells and high frequency of CD4+ T cells (which includes the subset of T regulatory cells) in the high ALC group. Low frequency of NK cells and potentially high frequency of inhibitory T regulatory cells may result in weaker immune responses against residual leukemia and may explain the poorer outcome of the high ALC group.Keywords
This publication has 28 references indexed in Scilit:
- Foxp3+ Regulatory T-cells and IL-2: The Moirai of T-cell Fates?Frontiers in Immunology, 2012
- Early lymphocyte recovery after intensive timed sequential chemotherapy for acute myelogenous leukemia: peripheral oligoclonal expansion of regulatory T cellsBlood, 2011
- Intensive chemotherapy for acute myeloid leukemia differentially affects circulating TC1, TH1, TH17 and TREG cellsBMC Immunology, 2010
- Depletion of endogenous tumor-associated regulatory T cells improves the efficacy of adoptive cytotoxic T-cell immunotherapy in murine acute myeloid leukemiaBlood, 2009
- Prognostic factors and risk assessment in chronic myelomonocytic leukemia: Validation study of the M.D. Anderson Prognostic Scoring SystemLeukemia & Lymphoma, 2007
- Activated natural killer cells from patients with acute myeloid leukemia are cytotoxic against autologous leukemic blasts in NOD/SCID miceLeukemia, 2005
- Four-Color Flow Cytometry Shows Strong Concordance With Bone Marrow Morphology and Cytogenetics in the Evaluation for MyelodysplasiaAmerican Journal of Clinical Pathology, 2005
- Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancerBlood, 2005
- Acute myeloid leukaemia cells secrete a soluble factor that inhibits T and NK cell proliferation but not cytolytic function – implications for the adoptive immunotherapy of leukaemiaClinical and Experimental Immunology, 2001
- A Proportional Hazards Model for the Subdistribution of a Competing RiskJournal of the American Statistical Association, 1999